, Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma, Nature, vol.511, pp.543-550, 2014.

M. A. Lemmon and J. Schlessinger, Cell signaling by receptor tyrosine kinases, Cell, vol.141, pp.1117-1134, 2010.

A. Ullrich, Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells, Nature, vol.309, pp.418-425, 1984.

A. Tomas, WASH and Tsg101/ALIX-dependent diversion of stressinternalized EGFR from the canonical endocytic pathway, Nat. Commun, vol.6, p.7324, 2015.

F. Capuani, Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells, Nat. Commun, vol.6, p.7999, 2015.

M. R. Torrisi, Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization, Mol. Biol. Cell, vol.10, pp.417-434, 1999.

J. S. Sebolt-leopold and R. Herrera, Targeting the mitogen-activated protein kinase cascade to treat cancer, Nat. Rev. Cancer, vol.4, pp.937-947, 2004.

P. J. Roberts and C. J. Der, Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer, Oncogene, vol.26, pp.3291-3310, 2007.

A. Sorkin and L. K. Goh, Endocytosis and intracellular trafficking of ErbBs, Exp. Cell Res, vol.315, pp.683-696, 2009.

D. Fiore and P. P. , Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells, Cell, vol.51, pp.1063-1070, 1987.

H. Kawamata, S. Kameyama, and R. Oyasu, In vitro and in vivo acceleration of the neoplastic phenotype of a low-tumorigenicity rat bladder carcinoma cell line by transfected transforming growth factor-alpha, Mol. Carcinog, vol.9, pp.210-219, 1994.

M. J. Hayman and P. J. Enrietto, Cell transformation by the epidermal growth factor receptor and v-erbB, Cancer Cells, vol.3, pp.302-307, 1991.

A. Henze, Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR, Nat. Commun, vol.5, p.5582, 2014.

B. K. Garvalov, PHD3 regulates EGFR internalization and signalling in tumours, Nat. Commun, vol.5, p.5577, 2014.
DOI : 10.1038/ncomms6577
URL : https://www.nature.com/articles/ncomms6577.pdf

H. Ying, Mig-6 controls EGFR trafficking and suppresses gliomagenesis, Proc. Natl Acad. Sci. USA, vol.107, pp.6912-6917, 2010.
DOI : 10.1073/pnas.0914930107
URL : http://europepmc.org/articles/pmc2872443?pdf=render

Y. Du, Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking, Oncogene, vol.33, pp.756-770, 2014.

R. I. Nicholson, J. M. Gee, and M. E. Harper, EGFR and cancer prognosis, Eur. J. Cancer, vol.37, pp.9-15, 2001.
DOI : 10.1016/s0959-8049(01)00231-3

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011.

J. Z. Rappoport and S. M. Simon, Endocytic trafficking of activated EGFR is AP2 dependent and occurs through preformed clathrin spots, J. Cell Sci, vol.122, pp.1301-1305, 2009.

J. Mazella, The 100-kDa neurotensin receptor is gp95/sortilin, a non-Gprotein-coupled receptor, J. Biol. Chem, vol.273, pp.26273-26276, 1998.
DOI : 10.1074/jbc.273.41.26273
URL : http://www.jbc.org/content/273/41/26273.full.pdf

J. Mazella, Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking?, Cell Signal, vol.13, pp.1-6, 2001.
DOI : 10.1016/s0898-6568(00)00130-3

C. M. Petersen, Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography, J. Biol. Chem, vol.272, pp.3599-3605, 1997.

E. G. Marcusson, B. F. Horazdovsky, J. L. Cereghino, E. Gharakhanian, and S. D. Emr, The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene, Cell, vol.77, pp.579-586, 1994.

T. Kim and B. L. Hempstead, NRH2 is a trafficking switch to regulate sortilin localization and permit proneurotrophin-induced cell death, EMBO J, vol.28, pp.1612-1623, 2009.
DOI : 10.1038/emboj.2009.118
URL : http://europepmc.org/articles/pmc2693153?pdf=render

E. M. Quistgaard, Ligands bind to Sortilin in the tunnel of a ten-bladed beta-propeller domain, Nat. Struct. Mol. Biol, vol.16, pp.96-98, 2009.

C. B. Vaegter, Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling, Nat. Neurosci, vol.14, pp.54-61, 2011.

C. M. Wilson, Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors, J. Cell Sci, vol.127, pp.3983-3997, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01059696

M. S. Nielsen, The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein, EMBO J, vol.20, pp.2180-2190, 2001.

M. Colombo, G. Raposo, and C. Théry, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, Annu. Rev. Cell Dev. Biol, vol.30, pp.255-289, 2014.

Y. Wei, EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance, Cell, vol.154, pp.1269-1284, 2013.

G. Carpenter, Receptors for epidermal growth factor and other polypeptide mitogens, Annu. Rev. Biochem, vol.56, pp.881-914, 1987.

J. Mazella, Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking?, Cell Signal, vol.13, pp.1-6, 2001.
DOI : 10.1016/s0898-6568(00)00130-3

E. Macia, Dynasore, a cell-permeable inhibitor of dynamin, Dev. Cell, vol.10, pp.839-850, 2006.
DOI : 10.1016/j.devcel.2006.04.002
URL : https://doi.org/10.1016/j.devcel.2006.04.002

A. V. Vieira, C. Lamaze, and S. L. Schmid, Control of EGF receptor signaling by clathrin-mediated endocytosis, Science, vol.274, pp.2086-2089, 1996.

K. Mesaki, K. Tanabe, M. Obayashi, N. Oe, and K. Takei, Fission of tubular endosomes triggers endosomal acidification and movement, PLoS ONE, vol.6, p.19764, 2011.

H. S. Wiley, The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor, J. Biol. Chem, vol.266, pp.11083-11094, 1991.

A. Nykjaer, Sortilin is essential for proNGF-induced neuronal cell death, Nature, vol.427, pp.843-848, 2004.

K. A. Stern, Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate hrs degradation, Mol. Cell Biol, vol.27, pp.888-898, 2007.
DOI : 10.1128/mcb.02356-05
URL : http://europepmc.org/articles/pmc1800687?pdf=render

G. M. Finan, H. Okada, and T. Kim, BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin, J. Biol. Chem, vol.286, pp.12602-12616, 2011.

A. A. Cooper and T. H. Stevens, Vps10p cycles between the late-Golgi and prevacuolar compartments in its function as the sorting receptor for multiple yeast vacuolar hydrolases, J. Cell Biol, vol.133, pp.529-541, 1996.

S. V. Sharma, D. W. Bell, J. Settleman, and D. A. Haber, Epidermal growth factor receptor mutations in lung cancer, Nat. Rev. Cancer, vol.7, pp.169-181, 2007.

B. M. Chung, Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src, BMC Cell Biol, vol.10, p.84, 2009.

A. Tomas, C. E. Futter, and E. R. Eden, EGF receptor trafficking: consequences for signaling and cancer, Trends Cell Biol, vol.24, pp.26-34, 2014.

B. Martin, Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis, Br. J. Cancer, vol.91, pp.2018-2025, 2004.

R. S. Saad, Y. L. Liu, H. Han, R. J. Landreneau, and J. F. Silverman, Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung, Hum. Pathol, vol.35, pp.3-7, 2004.

L. M. Solis, Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome, Cancer, vol.118, pp.2889-2899, 2012.

J. Gao, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal, vol.6, p.1, 2013.

E. Cerami, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, vol.2, pp.401-404, 2012.

X. Li and M. Donowitz, Fractionation of subcellular membrane vesicles of epithelial and non-epithelial cells by OptiPrep TM density gradient ultracentrifugation, Methods Mol. Biol, vol.1174, pp.85-99, 2014.

B. Gy?rffy, P. Surowiak, J. Budczies, and A. Lánczky, Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer, PLoS ONE, vol.8, p.82241, 2013.

A. R. Li, EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression, J. Mol. Diagn, vol.10, pp.242-248, 2008.

M. Ladanyi and W. Pao, Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond, Mod. Pathol, vol.21, pp.16-22, 2008.
DOI : 10.1038/modpathol.3801018
URL : https://www.nature.com/articles/3801018.pdf

Y. Ohsaki, Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression, Oncol. Rep, vol.7, pp.603-607, 2000.

K. Inamura, H. Ninomiya, Y. Ishikawa, and O. Matsubara, Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features?, Arch. Pathol. Lab. Med, vol.134, pp.66-72, 2010.

L. B. Alexandrov, Signatures of mutational processes in human cancer, Nature, vol.500, pp.415-421, 2013.

C. Francavilla, Multilayered proteomics reveals molecular switches dictating ligand-dependent EGFR trafficking, Nat. Struct. Mol. Biol, vol.23, pp.608-618, 2016.

S. Roselli, Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion, Oncotarget, vol.6, pp.10473-10486, 2015.

F. Massa, Impairement of HT29 cancer cells cohesion by the soluble form of neurotensin receptor-3, Genes Cancer, vol.5, pp.240-249, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02108990

F. Ghaemimanesh, The effect of sortilin silencing on ovarian carcinoma cells, Avicenna J. Med. Biotechnol, vol.6, pp.169-177, 2014.

A. Magnaudeix, PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins, Neurobiol. Aging, vol.34, pp.770-790, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00872290

H. Greulich, Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants, PLoS Med, vol.2, p.313, 2005.
DOI : 10.1371/journal.pmed.0020313
URL : https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.0020313&type=printable

R. E. Carter and A. Sorkin, Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera, J. Biol. Chem, vol.273, pp.35000-35007, 1998.

S. Hsu and M. Hung, Characterization of a novel tripartite nuclear localization sequence in the EGFR family, J. Biol. Chem, vol.282, pp.10432-10440, 2007.

R. Pirker, EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study, Lancet Oncol, vol.13, pp.33-42, 2012.

V. J. Tuominen, S. Ruotoistenmäki, A. Viitanen, M. Jumppanen, and J. Isola, ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67, Breast Cancer Res, vol.12, p.56, 2010.

J. Budczies, Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization, PLoS ONE, vol.7, p.51862, 2012.
DOI : 10.1371/journal.pone.0051862
URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0051862&type=printable